Trial Profile
Double-blind, Randomized, Placebo-controlled, Dose-escalating, Exploratory Study to Investigate the Pharmacokinetics, Safety and Tolerability of Multiple Doses of YM178 OCAS-M in Healthy Young Male and Female Subjects and Healthy Elderly Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jul 2013
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 28 Nov 2011 New trial record